In one paragraphArticle in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Fatemah S BasingabDepartment of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21859, Saudi Arabia.ORCID 0000-0001-5251-559X Reem A AlzahraniDepartment of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21859, Saudi Arabia.
Aisha A AlrofaidiDepartment of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21859, Saudi Arabia.ORCID 0000-0002-0416-2723 Ahmed S BarefahHematology Department, Faculty of Medicine, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah 21859, Saudi Arabia.ORCID 0000-0003-2009-3817 Rawan M HammadHematology Department, Faculty of Medicine, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah 21859, Saudi Arabia.
Hadil M AlahdalDepartment of Biology, Faculty of Science, Princes Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia.
Jehan S AlrahimiDepartment of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21859, Saudi Arabia.ORCID 0000-0001-7803-2078 Kawther A ZaherImmunology Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21859, Saudi Arabia.ORCID 0000-0003-0909-6558 Ali H AlgiraigriHematology Department, Faculty of Medicine, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah 21859, Saudi Arabia.
Mai M El-DalySpecial Infectious Agents Unit-BSL3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21859, Saudi Arabia.ORCID 0000-0002-3864-523X Saleh A AlkarimDepartment of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21859, Saudi Arabia.ORCID 0000-0002-2217-1615 Alia M AldahlawiDepartment of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21859, Saudi Arabia.ORCID 0000-0001-9599-050X Funding
the Ministry of Education and Deanship of Scientific Research (DSR) at King Abdulaziz Univer-sity (KAU), Jeddah. IFPRC‑217-130-2020
6 · The paper itselfAbstract
Herpesvirus entry mediator (HVEM) is a molecular switch that can modulate immune responses against cancer. The significance of HVEM as an immune checkpoint target and a potential prognostic biomarker in malignancies is still controversial. This study aims to determine whether HVEM is an immune checkpoint target with inhibitory effects on anti-tumor CD4
Indexed as
Biomarkers, TumorReceptors, Tumor Necrosis Factor, Member 14AdultAgedCD4-Positive T-LymphocytesCell Line, TumorCell ProliferationFemaleHEK293 CellsHumansK562 CellsMaleMiddle AgedPrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosisYoung AdultBiomarkers, TumorReceptors, Tumor Necrosis Factor, Member 14TNFRSF14 protein, humanacute lymphocytic leukemiaCD4+ T cellsco-inhibitory moleculesherpesvirus entry mediatorimmune checkpoint blockadeimmune checkpoint receptor
Identifiers
PMID38785930
PMCPMC11117912
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390